沖縄県から　6/21 ①感染拡大を防ぐためのお願い ■発熱等の体調不良時は外出を控える ■手洗や換気などの基本的な感染対策の継続をお願いします ■推奨される場面でのマスク着用 ②救急医療を守るためのお願い ■事前に準備しましょう ■軽症の方は救急受診を控えてください pref.okinawa.jp/site/covid19_p…

貴重な症例を見にも来ないレジデントは成長の機会が限られてるって気づいてないんだろうな。まぁいい。置いていくだけ。

こんな場末の野戦病院に20年間もよく勤務してきたと思う。いつでも辞められるから、もう少しだけ頑張ろう、耐えようと毎日のように考えていたなぁ。

Thrilled to share our most recent Leukemia Journal “SETBP1 is dispensable for normal and malignant hematopoiesis”. In collaboration with outstanding Japanese researchers, we extensively examined the roles of endogenous SETBP1 in the hematopoietic system. rdcu.be/dg6Gh

Jordi Xiol PD-1 has single agent activity. Anti CD47 (magro) had no single agent activity in MDS. Drugs with no single agent activity rarely if ever improve outcomes in RCTs when used in combination

Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia - Matthews - 2023 - American Journal of Hematology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj…

We are expanding! Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT) at Moffitt has positions open for transplant physicians specializing in myeloid disorders. …nter-careers-internal.hctsportals.com/jobs/1217283-b…

Watch experts Régis Peffault de Latour, Alicia Rovó, and Phillip Scheinberg as they discuss aplastic anemia diagnosis and treatment options supported by patient cases. springerhealthcareime.events/aplastic-anemi…

The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin–transferrin receptor 1 axis loom.ly/_-a4ITg

It is a great honor to be involved in #BPDCN reseach. We reported a patient diagnosed with #BPDCN limited to the skin and MDS in the BM. Using NGS and CNA, we confirmed a common clonal origin of both conditions. pubmed.ncbi.nlm.nih.gov/37558659/

Impact of Preexisting Autoimmune Disease on Myelodysplastic Syndromes Outcomes: A population Analysis pubmed.ncbi.nlm.nih.gov/37729616/

自民党の顧問弁護士との打ち合わせも警察への被害届も民事訴訟も、やるなら粛々とやればいいものを、いちいちXにポストするのは、国会議員としての権力を振りかざし、飯山陽を脅すためだろう。自民党議員の一民間人に対する不当な脅迫、リーガルハラスメントの実態を、全国民に見ていただくがいい。

今日であの日から17年。 偶然にも昨日から故郷福岡で仕事。 朝、車を飛ばして話してきました。 短いような長いような17年。 相変わらず1人でやってますわ。 終わって博多の酒場に繰り出すわ。 ほにゃな。

Dr Naval Daver, M.D. & I have signed the treaty of Kyoto to end all disagreements in the field & to reconcile all the differences in classification, risk stratification & response assessment between higher risk #MDSsm & #AMLsm

Enjoyed reading this analysis of HMA-VEN & IC in pt ≥60yo w/ newly-dx IDHm AML led by Shai Shimony Maximilian Stahl Rory M. Shallis, MD et al #leusm -151 pt (81 IC 70 HMA-VEN) -cCR rate 67% for both groups -2y OS 45% for cohort (51% for IC, 35% for HMA-VEN p=0.14) onlinelibrary.wiley.com/doi/full/10.10…

BMT CI is hosting the patient reunion, and we are looking for sponsors for the event celebrating our program's 35th anniversary. If anyone is interested, please follow the link below. Our patients will be appreciative of any help! moffitt.org/treatments/blo…

What better way 2 begin the academic year than 2 learn the “16+2” molecular subgroups of #MDSsm …. Never a better time to be a #hematopathologist 🎉 Going frm 3 genetically defined groups (multi TP53, SF3B1 and del 5q) of MDS to 16 👇🏼is a major advancement in our understanding

Our paper on the biomarker of selinexor (XPO1 inhibitor, FDA approved for R/R MM and DLBCL) sensitivity has been published online in Leukemia (rdcu.be/dNofH). Via CRISPR dropout screens, we found that DDX19 homologue dosage is key for selinexor sensitivity.

Wow, out just in time for your weekend reading-- our last four years labor of love "Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition"!! nature.com/articles/s4137… Congratulations to first author newly minted Dr. Sana Chaudhry! Sylvester Comprehensive Cancer Center 🧵